Natus Unveils Revolutionary BrainWatch EEG Solution at AES Annual Meeting

Natus Unveils BrainWatch EEG Solution at AES

Natus Medical Incorporated is making waves in the medical technology field with the innovative launch of its FDA-cleared BrainWatch™ point-of-care EEG solution. This highly anticipated device will be showcased for the first time at the American Epilepsy Society (AES) Annual Meeting taking place in Los Angeles from December 6 to 10, 2024.

The unveiling comes after BrainWatch received its 510(k) clearance in November 2024, which has set the stage for Natus to collaborate with top-tier hospitals and healthcare facilities. These collaborations aim to identify the first users of the BrainWatch system, gathering valuable feedback ahead of its official market launch planned for early 2025.

What Makes BrainWatch Stand Out?

Designed for rapid deployment, BrainWatch can be set up in less than five minutes. This quick installation allows for immediate intervention in acute care settings, making it a game-changer for patient outcomes. The system streamlines treatment decisions by offering neurology support right when it's needed most.

Chris Landon, CEO of Natus, expressed enthusiasm about the product's potential: "BrainWatch is designed to bring the reliability and trust of Natus EEG solutions into critical care environments."

The ease of use ensures that high-quality EEG access can reach more communities, allowing local healthcare providers to consult with neurologists remotely. This feature significantly enhances the efficiency of care, enabling timely intervention and treatment strategies.

The Growing Market for Point-of-Care EEG

The market for point-of-care EEG devices is rapidly expanding, with estimates suggesting it could reach $98 million by 2027. As a leader in the field, Natus aims to set a new standard for reliable EEG technology in critical care contexts with BrainWatch.

In addition to the BrainWatch debut, Natus will feature several cutting-edge products at its booth (#1819) in the Los Angeles Convention Center. Attendees can expect to see the latest in NeuroWorks 10 software, the innovative autoSCORE AI, the Trex HD Monitoring EZ-Case System, and the Moberg Multimodal Monitoring system. Additionally, new products like Disposable MR Conditional Electrodes and EC2+ conductive paste for EEG cup electrodes will also be highlighted.

About Natus

Natus Medical is recognized and trusted by healthcare providers worldwide as a premier source for screening, diagnosing, and treating disorders of the brain, neural pathways, and sensory nervous systems. With a strong commitment to offering top-tier solutions that support clinicians, Natus aims to enhance patient outcomes and overall quality of life.

For more details about Natus and its innovative solutions, visit www.natus.com/neuro.

Conclusion

The launch of BrainWatch signifies a transformative step in EEG technology, showcasing Natus's commitment to enhancing patient care through advanced solutions. With its user-friendly design and swift implementation, BrainWatch is set to revolutionize the approach to neurodiagnostics in critical settings. The upcoming AES Annual Meeting will undoubtedly make for an exciting platform for this groundbreaking product.